Alpine Woods Capital Investors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $537K | Sell |
|
|||||
|
2025
Q2 | $413K | Buy |
|
|||||
|
2025
Q1 | $226K | Sell |
|
|||||
|
2024
Q4 | $275K | Buy |
|
|||||
|
2024
Q3 | $314K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $3.24M | Sell |
|
|||||
|
2021
Q3 | $7.57M | Buy |
|
|||||
|
2021
Q2 | $10.9M | Buy |
|
|||||
|
2021
Q1 | $4.83M | Buy |
|
|||||
|
2020
Q4 | $5.39M | Buy |
|
|||||
|
2020
Q3 | $2.37M | Buy |
|
|||||
|
2020
Q2 | $1.84M | Buy |
|
|||||
|
2020
Q1 | $600K | Buy |
|
|||||
|
2019
Q4 | $616K | Sell |
|
|||||
|
2019
Q3 | $416K | Hold |
|
|||||
|
2019
Q2 | $478K | Hold |
|
|||||
|
2019
Q1 | $363K | Hold |
|
|||||
|
2018
Q4 | $290K | Buy |
|
|||||
|
2018
Q3 | $449K | Buy |
|